Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases.

[1]  Houeto Jean-Luc.  [Parkinson's disease]. , 2022, La Revue du praticien.

[2]  F. Coppedè,et al.  Lack of association between the APEX1 Asp148Glu polymorphism and sporadic amyotrophic lateral sclerosis , 2010, Neurobiology of Aging.

[3]  M. Tabaton,et al.  JNK and ERK1/2 pathways have a dual opposite effect on the expression of BACE1 , 2009, Neurobiology of Aging.

[4]  N. Zawia,et al.  The Environment, Epigenetics and Amyloidogenesis , 2009, Alzheimer's & Dementia.

[5]  N. Bresolin,et al.  Absence of angiogenic genes modification in Italian ALS patients , 2008, Neurobiology of Aging.

[6]  Colin C. McCulloch,et al.  Exploring gene-environment interactions in Parkinson’s disease , 2008, Human Genetics.

[7]  J. Jia,et al.  The association of the regulatory region of the presenilin-2 gene with Alzheimer's disease in the Northern Han Chinese population , 2008, Journal of the Neurological Sciences.

[8]  K. Garber.  The Elusive ALS Genes , 2008, Science.

[9]  Demao Chen,et al.  Alzheimer's Disease (AD)-Like Pathology in Aged Monkeys after Infantile Exposure to Environmental Metal Lead (Pb): Evidence for a Developmental Origin and Environmental Link for AD , 2008, The Journal of Neuroscience.

[10]  F. Panza,et al.  Lifestyle-related factors in predementia and dementia syndromes , 2008, Expert review of neurotherapeutics.

[11]  Jonathan Pevsner,et al.  DNA methylation signatures within the human brain. , 2007, American journal of human genetics.

[12]  A. Holland,et al.  Gene expression profiling in the adult Down syndrome brain. , 2007, Genomics.

[13]  P. S. St George-Hyslop,et al.  Association between SORL1 and Alzheimer's disease in a genome-wide study , 2007, Neuroreport.

[14]  Gang Hu,et al.  Coffee and tea consumption and the risk of Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[15]  Xiang Gao,et al.  Prospective study of dietary pattern and risk of Parkinson disease. , 2007, The American journal of clinical nutrition.

[16]  M. Findeis.  The role of amyloid β peptide 42 in Alzheimer's disease , 2007 .

[17]  M. Szyf,et al.  The dynamic epigenome and its implications in toxicology. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  Michael S. Wolfe,et al.  Presenilin: Running with Scissors in the Membrane , 2007, Cell.

[19]  B. Traynor,et al.  Genetics of sporadic amyotrophic lateral sclerosis. , 2007, Human molecular genetics.

[20]  L. H. van den Berg,et al.  Lifetime occupation, education, smoking, and risk of ALS , 2007, Neurology.

[21]  Honglei Chen,et al.  Head injury and amyotrophic lateral sclerosis. , 2007, American journal of epidemiology.

[22]  F. Domann,et al.  An epigenetic perspective on the free radical theory of development. , 2007, Free radical biology & medicine.

[23]  Andrew M. Allen.  Epigenetic alterations and cancer: new targets for therapy. , 2007, IDrugs : the investigational drugs journal.

[24]  R. Jaenisch,et al.  DNA Methylation in the Human Cerebral Cortex Is Dynamically Regulated throughout the Life Span and Involves Differentiated Neurons , 2007, PloS one.

[25]  E. Tan,et al.  The role of common genetic risk variants in Parkinson disease , 2007, Clinical genetics.

[26]  C. Hoogenraad,et al.  Motor Neuron Disease-Associated Mutant Vesicle-Associated Membrane Protein-Associated Protein (VAP) B Recruits Wild-Type VAPs into Endoplasmic Reticulum-Derived Tubular Aggregates , 2007, The Journal of Neuroscience.

[27]  Philippe Amouyel,et al.  Genetic heterogeneity of Alzheimer's disease: Complexity and advances , 2007, Psychoneuroendocrinology.

[28]  I. König,et al.  Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease , 2007, European Journal of Human Genetics.

[29]  H. Cai,et al.  Alsin and the Molecular Pathways of Amyotrophic Lateral Sclerosis , 2007, Molecular Neurobiology.

[30]  M. Smith,et al.  Causes of oxidative stress in Alzheimer disease , 2007, Cellular and Molecular Life Sciences.

[31]  M. Tabaton,et al.  The molecular link between β- and γ-secretase activity on the amyloid β precursor protein , 2007, Cellular and Molecular Life Sciences.

[32]  K. Marder,et al.  Pooled analysis of tobacco use and risk of Parkinson disease. , 2007, Archives of neurology.

[33]  P. Riso,et al.  Mutation of SOD1 in ALS: a gain of a loss of function. , 2007, Human molecular genetics.

[34]  Michael Jerrett,et al.  A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities. , 2007, Environmental research.

[35]  J. Borlak,et al.  A new paradigm in toxicology and teratology: altering gene activity in the absence of DNA sequence variation. , 2007, Reproductive toxicology.

[36]  Laura Fratiglioni,et al.  The epidemiology of the dementias: an update , 2007, Current opinion in psychiatry.

[37]  M. Gatei,et al.  Senataxin, defective in ataxia oculomotor apraxia type 2, is involved in the defense against oxidative DNA damage , 2007, The Journal of cell biology.

[38]  A. Elbaz.  [Parkinson's disease and rural environment]. , 2007, La Revue du praticien.

[39]  F. Coppedè,et al.  Association of the hOGG1 Ser326Cys polymorphism with sporadic amyotrophic lateral sclerosis , 2007, Neuroscience Letters.

[40]  E. Abel.  Football Increases the Risk for Lou Gehrig's Disease, Amyotrophic Lateral Sclerosis , 2007, Perceptual and motor skills.

[41]  I. Loy-English,et al.  Gender differences in dementia risk factors. , 2007, Gender medicine.

[42]  Miguel Santibez,et al.  Occupational risk factors in Alzheimers disease: a review assessing the quality of published epidemiological studies , 2007, Occupational and Environmental Medicine.

[43]  A. Feinberg.  Phenotypic plasticity and the epigenetics of human disease , 2007, Nature.

[44]  John Peterson Myers,et al.  Environmental Exposures and Gene Regulation in Disease Etiology , 2007, Environmental health perspectives.

[45]  N. Scott,et al.  Gene-environment interactions in parkinsonism and Parkinson’s disease: the Geoparkinson study , 2007, Occupational and Environmental Medicine.

[46]  D. Campion,et al.  APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[47]  Longfei Jia,et al.  Genetic association between polymorphisms of Pen2 gene and late onset Alzheimer's disease in the North Chinese population , 2007, Brain Research.

[48]  R. Jirtle,et al.  Environmental epigenomics and disease susceptibility , 2007, Nature Reviews Genetics.

[49]  N. Zawia,et al.  How and when environmental agents and dietary factors affect the course of Alzheimer's disease: the "LEARn" model (latent early-life associated regulation) may explain the triggering of AD. , 2007, Current Alzheimer research.

[50]  F. Coppedè,et al.  A Ser326Cys polymorphism in the DNA repair gene hOGG1 is not associated with sporadic Alzheimer's disease , 2007, Neuroscience Letters.

[51]  H. Gurvit,et al.  The Arg194Trp polymorphism in DNA repair gene XRCC1 and the risk for sporadic late-onset Alzheimer's disease , 2007, Neurological Sciences.

[52]  M. Farrer,et al.  Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. , 2007, Parkinsonism & related disorders.

[53]  J. Ioannidis,et al.  Meta-Analysis in Genome-Wide Association Datasets: Strategies and Application in Parkinson Disease , 2007, PLoS ONE.

[54]  Colm Cunningham,et al.  Systemic infections and inflammation affect chronic neurodegeneration , 2007, Nature Reviews Immunology.

[55]  K. Lunetta,et al.  The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease , 2007, Nature Genetics.

[56]  N. Scott,et al.  Environmental risk factors for Parkinson’s disease and parkinsonism: the Geoparkinson study , 2007, Occupational and Environmental Medicine.

[57]  R. Trent,et al.  Are metallothionein genes silenced in ALS? , 2007, Toxicology letters.

[58]  S. Murphy,et al.  Cancer Susceptibility: Epigenetic Manifestation of Environmental Exposures , 2007, Cancer journal.

[59]  A. Al-Chalabi,et al.  Three soccer playing friends with simultaneous amyotrophic lateral sclerosis , 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[60]  R. Pamphlett,et al.  An epigenetic analysis of SOD1 and VEGF in ALS , 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[61]  M. MacDonald,et al.  Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age , 2006, Neurology.

[62]  M. Eriguchi,et al.  3-Methylglutaconic aciduria type I causes leukoencephalopathy of adult onset , 2006, Neurology.

[63]  Bastiaan R Bloem,et al.  Gender differences in Parkinson’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[64]  Matthew T. Lorincz.  Clinical implications of Parkinson's disease genetics. , 2006, Seminars in neurology.

[65]  P. Ragonese,et al.  Implications for Estrogens in Parkinson's Disease , 2006, Annals of the New York Academy of Sciences.

[66]  F. Domann,et al.  Epigenetic Regulation of Manganese Superoxide Dismutase Expression in Human Breast Cancer Cells , 2006, Epigenetics.

[67]  Jan Gründemann,et al.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase , 2006, Nature Genetics.

[68]  R. Paffenbarger,et al.  Physical activity and risk of Parkinson’s disease: a prospective cohort study , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[69]  J. Gorell,et al.  Whole-Body Lifetime Occupational Lead Exposure and Risk of Parkinson’s Disease , 2006, Environmental health perspectives.

[70]  Aldo Quattrone,et al.  Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. , 2006, JAMA.

[71]  M. Kivipelto,et al.  Cholesterol as a risk factor for Alzheimer's disease – epidemiological evidence , 2006, Acta neurologica Scandinavica. Supplementum.

[72]  David Oakes,et al.  Head injury and Parkinson's disease risk in twins , 2006, Annals of neurology.

[73]  K. Sleegers,et al.  Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. , 2006, American journal of human genetics.

[74]  F. Dick,et al.  Parkinson's disease and pesticide exposures. , 2006, British medical bulletin.

[75]  M. Piras,et al.  Genetic study of Sardinian patients with Alzheimer's disease , 2006, Neuroscience Letters.

[76]  D. Goldstein,et al.  UCHL‐1 is not a Parkinson's disease susceptibility gene , 2006, Annals of neurology.

[77]  J. Borlak,et al.  N-acetyltransferase 2 (NAT2) gene polymorphisms in Parkinson's disease , 2006, BMC Medical Genetics.

[78]  H. Horvitz,et al.  A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia , 2006, Neurology.

[79]  B. Strooper,et al.  Presenilin clinical mutations can affect γ‐secretase activity by different mechanisms , 2006, Journal of neurochemistry.

[80]  R. Ricciarelli,et al.  Evidence against the overexpression of APP in down syndrome , 2006, IUBMB life.

[81]  Robert H. Brown,et al.  Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS) , 2006, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[82]  Jack A. Taylor,et al.  Lead Exposure as a Risk Factor for Amyotrophic Lateral Sclerosis , 2006, Neurodegenerative Diseases.

[83]  C. Ross,et al.  Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[84]  C. Tanner,et al.  Excessive daytime sleepiness and subsequent development of Parkinson disease , 2005, Neurology.

[85]  J. Schulz,et al.  Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. , 2005, Human molecular genetics.

[86]  R. Marconi,et al.  Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes , 2005, Neurology.

[87]  E. Granieri,et al.  Amyotrophic lateral sclerosis, rural environment and agricultural work in the Local Health District of Ferrara, Italy, in the years 1964–1998 , 2005, Journal of Neurology.

[88]  F. Coppedè,et al.  Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients , 2005, Neurobiology of Aging.

[89]  A. Chiò,et al.  Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. , 2005, Brain : a journal of neurology.

[90]  G. Perry,et al.  β‐Site APP cleaving enzyme up‐regulation induced by 4‐hydroxynonenal is mediated by stress‐activated protein kinases pathways , 2005, Journal of neurochemistry.

[91]  F. D’Anselmi,et al.  S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production , 2005, Molecular and Cellular Neuroscience.

[92]  S. Ennis,et al.  A novel candidate region for ALS on chromosome 14q11.2 , 2004, Neurology.

[93]  Andrew Lees,et al.  Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.

[94]  T. Gillingwater,et al.  A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. , 2004, American journal of human genetics.

[95]  H. Walach,et al.  Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator. , 2004, Neuro endocrinology letters.

[96]  Philippe Amouyel,et al.  α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[97]  M. Kamboh,et al.  Molecular Genetics of Late‐Onset Alzheimer's Disease , 2004, Annals of human genetics.

[98]  M. Thun,et al.  Prospective study of cigarette smoking and amyotrophic lateral sclerosis. , 2004, American journal of epidemiology.

[99]  A J Lees,et al.  Tau gene and Parkinson’s disease: a case–control study and meta-analysis , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[100]  John W Griffin,et al.  DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). , 2004, American journal of human genetics.

[101]  R. Nussbaum,et al.  Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.

[102]  P. Lockhart,et al.  Parkin genetics: one model for Parkinson's disease. , 2004, Human molecular genetics.

[103]  D. Goldstein,et al.  UCHL1 is a Parkinson's disease susceptibility gene. , 2004 .

[104]  C. Armon.  Occurrence of amyotrophic lateral sclerosis among Gulf War veterans , 2004, Neurology.

[105]  Christophe Tzourio,et al.  CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease , 2004, Annals of neurology.

[106]  P. Lockhart,et al.  DJ-1 mutations are a rare cause of recessively inherited early onset parkinsonism mediated by loss of protein function , 2004, Journal of Medical Genetics.

[107]  J. Hoenicka,et al.  The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.

[108]  D. Blacker,et al.  PEN2 is not a genetic risk factor for Alzheimer’s disease in a large family sample , 2004, Neurology.

[109]  M. Franceschi,et al.  Nicastrin gene in familial and sporadic Alzheimer's disease , 2003, Neuroscience Letters.

[110]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[111]  D. Bennett,et al.  Alzheimer disease in the US population: prevalence estimates using the 2000 census. , 2003, Archives of neurology.

[112]  C. Johansen,et al.  Neurodegenerative Diseases in Welders and Other Workers Exposed to High Levels of Magnetic Fields , 2003, Epidemiology.

[113]  B. Liu,et al.  Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. , 2003, Environmental health perspectives.

[114]  S. Antonarakis,et al.  Specific BACE1 genotypes provide additional risk for late‐onset alzheimer disease in APOE ε4 carriers , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[115]  Shin J. Oh,et al.  Mutant dynactin in motor neuron disease , 2003, Nature Genetics.

[116]  F. Sung,et al.  Association between occupational exposure to power frequency electromagnetic fields and amyotrophic lateral sclerosis: a review. , 2003, American journal of industrial medicine.

[117]  J. Joseph,et al.  Amyloid-β and τ serve antioxidant functions in the aging and Alzheimer brain , 2002 .

[118]  P. Lansbury,et al.  The UCH-L1 Gene Encodes Two Opposing Enzymatic Activities that Affect α-Synuclein Degradation and Parkinson's Disease Susceptibility , 2002, Cell.

[119]  G. Perry,et al.  Oxidative Stress Increases Expression and Activity of BACE in NT2 Neurons , 2002, Neurobiology of Disease.

[120]  P. S. St George-Hyslop,et al.  The gene encoding nicastrin, a major gamma-secretase component, modifies risk for familial early-onset Alzheimer disease in a Dutch population-based sample. , 2002, American journal of human genetics.

[121]  Richard D Fetter,et al.  Dynactin Is Necessary for Synapse Stabilization , 2002, Neuron.

[122]  Robert H. Brown,et al.  Rats Expressing Human Cytosolic Copper–Zinc Superoxide Dismutase Transgenes with Amyotrophic Lateral Sclerosis: Associated Mutations Develop Motor Neuron Disease , 2001, The Journal of Neuroscience.

[123]  M. Pericak-Vance,et al.  The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis , 2001, Nature Genetics.

[124]  P. Worms.  The epidemiology of motor neuron diseases: a review of recent studies , 2001, Journal of the Neurological Sciences.

[125]  C. Woods,et al.  Kufor-Rakeb syndrome, pallido-pyramidal degeneration with supranuclear upgaze paresis and dementia, maps to 1p36 , 2001, Journal of medical genetics.

[126]  J. Houwing-Duistermaat,et al.  Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. , 2001, American journal of human genetics.

[127]  A. Nunomura,et al.  Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[128]  J. Haines,et al.  Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. , 2000, JAMA.

[129]  Shinsei Minoshima,et al.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase , 2000, Nature Genetics.

[130]  J. Langston,et al.  Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine exposure , 1999, Annals of neurology.

[131]  A. Hofman,et al.  Genetic association of the presenilin-1 regulatory region with early-onset Alzheimer's disease in a population-based sample , 1999, European Journal of Human Genetics.

[132]  C. Masters,et al.  Aqueous Dissolution of Alzheimer’s Disease Aβ Amyloid Deposits by Biometal Depletion* , 1999, The Journal of Biological Chemistry.

[133]  R. Haley,et al.  Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans. , 1999, Toxicology and applied pharmacology.

[134]  C. Hayward,et al.  Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis , 1999, Neurology.

[135]  J W Langston,et al.  Parkinson disease in twins: an etiologic study. , 1999, JAMA.

[136]  A. Sun,et al.  Oxidative Stress and Neurodegenerative Disorders , 1998, Journal of Biomedical Science.

[137]  A. Blackburn,et al.  Parkinson's disease, pesticides, and glutathione transferase polymorphisms , 1998, The Lancet.

[138]  Georg Auburger,et al.  The ubiquitin pathway in Parkinson's disease , 1998, Nature.

[139]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[140]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[141]  M. Farrer,et al.  Molecular mapping of alzheimer‐type dementia in Down's syndrome , 1998, Annals of neurology.

[142]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[143]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[144]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[145]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[146]  D. Coggon,et al.  Aluminum Concentrations in Drinking Water and Risk of Alzheimer's Disease , 1997, Epidemiology.

[147]  N. Hirokawa,et al.  Microtubule-associated proteins regulate microtubule function as the track for intracellular membrane organelle transports. , 1996, Cell structure and function.

[148]  C. Bergeron,et al.  Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories , 1996, Neurology.

[149]  J. Rommens,et al.  Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene , 1995, Nature.

[150]  G. Schellenberg,et al.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.

[151]  J. Zweier,et al.  Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide , 1995, Nature Medicine.

[152]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[153]  J. Haines,et al.  Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33–q35 , 1994, Nature Genetics.

[154]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[155]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[156]  G. Kisby,et al.  Content of the neurotoxins cycasin (methylazoxymethanol β‐D‐glucoside) and BNLAA (β‐N‐methylamino‐L‐alanine) in cycad flour prepared by Guam Chamorros , 1992, Neurology.

[157]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[158]  P. Weiler.  The public health impact of Alzheimer's disease. , 1987, American journal of public health.

[159]  A. Ryszka,et al.  Afferent connections of the laterodorsal thalamic nucleus in the rat , 1979, Neuroscience Letters.

[160]  A. Guberman,et al.  Cerebral lesions in familial amyotrophic lateral sclerosis and dementia , 1973, Acta Neuropathologica.

[161]  Nananda F Col,et al.  Menopause , 2009, Annals of Internal Medicine.

[162]  J. Ballenger,et al.  Dietary patterns and risk of dementia: The Three-City cohort study , 2009 .

[163]  K. Buckwalter,et al.  Evidence supporting nutritional interventions for persons in early stage Alzheimer’s disease (AD) , 2008, The journal of nutrition, health & aging.

[164]  G. Casadesus,et al.  Menopause, estrogen, and gonadotropins in Alzheimer's disease. , 2008, Advances in clinical chemistry.

[165]  Nir Giladi,et al.  Advances in the genetics of Parkinson's disease , 2008, Acta Pharmacologica Sinica.

[166]  A. J. Slater,et al.  Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. , 2008, Archives of neurology.

[167]  Frank Baas,et al.  Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis , 2008, Nature Genetics.

[168]  D. Blacker,et al.  Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.

[169]  C. Santos-Rebouças,et al.  Implication of abnormal epigenetic patterns for human diseases , 2007, European Journal of Human Genetics.

[170]  F. D’Anselmi,et al.  gamma-Secretase is differentially modulated by alterations of homocysteine cycle in neuroblastoma and glioblastoma cells. , 2007, Journal of Alzheimer's disease : JAD.

[171]  M. Barcikowska,et al.  Two polymorphisms of presenilin-2 gene (PSEN2) 5′ regulatory region are not associated with Alzheimer’s disease (AD) in the Polish population , 2007, Journal of Neural Transmission.

[172]  Ze Yang,et al.  Genetic association of BACE1 gene polymorphism C786G with late-onset Alzheimer’s disease in Chinese , 2007, Journal of Molecular Neuroscience.

[173]  Federico V Pallardó,et al.  Mitochondrial oxidant signalling in Alzheimer's disease. , 2007, Journal of Alzheimer's disease : JAD.

[174]  R. Vink,et al.  Traumatic brain injury and Alzheimer's disease: a review. , 2007, Progress in brain research.

[175]  Xiongwei Zhu,et al.  The key role of oxidative stress in alzheimer's disease , 2007 .

[176]  M. Findeis.  The role of amyloid beta peptide 42 in Alzheimer's disease. , 2007, Pharmacology & therapeutics.

[177]  M. Tabaton,et al.  The molecular link between beta- and gamma-secretase activity on the amyloid beta precursor protein. , 2007, Cellular and molecular life sciences : CMLS.

[178]  G. Mellick.  CYP450, genetics and Parkinson's disease: gene x environment interactions hold the key. , 2006, Journal of neural transmission. Supplementum.

[179]  D. Campion,et al.  APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy , 2006, Nature Genetics.

[180]  S. Belli,et al.  Proportionate mortality of Italian soccer players: Is amyotrophic lateral sclerosis an occupational disease? , 2004, European Journal of Epidemiology.

[181]  Philippe Amouyel,et al.  Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. , 2004, Lancet.

[182]  A. Singleton,et al.  alpha-Synuclein locus triplication causes Parkinson's disease. , 2003, Science.

[183]  Sheryl Zimmerman,et al.  The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances. , 2002, Annual review of public health.

[184]  J. Joseph,et al.  Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain. , 2002, Free radical biology & medicine.

[185]  J. Houwing-Duistermaat,et al.  PARK 7 , a Novel Locus for Autosomal Recessive Early-Onset Parkinsonism , on Chromosome 1 p 36 , 2001 .

[186]  S. Hadano,et al.  A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2 , 2001, Nature Genetics.

[187]  E M Wijsman,et al.  The number of trait loci in late-onset Alzheimer disease. , 2000, American journal of human genetics.

[188]  M. Smith,et al.  Diet and oxidative stress: a novel synthesis of epidemiological data on Alzheimer's disease. , 1999, Journal of Alzheimer's disease : JAD.

[189]  W. Grant.  Dietary Links to Alzheimer's Disease , 1997 .

[190]  G. Kisby,et al.  Content of the neurotoxins cycasin (methylazoxymethanol beta-D-glucoside) and BMAA (beta-N-methylamino-L-alanine) in cycad flour prepared by Guam Chamorros. , 1992, Neurology.